Levobupivacaine Hydrochloride from China
Levobupivacaine hydrochloride is the S-enantiomer of bupivacaine, offering reduced cardiotoxicity. Classified under HTS 2924.29.71.00 as an aromatic cyclic amide per additional U.S. note 3. Meets chapter requirements for separate chemically defined stereoisomers.
Duty Rate — China → United States
137.5%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.3112.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of China, as provided for in U.S. note 52 to this subchapter
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
Import Tips
• Provide chiral HPLC analysis confirming >99% enantiomeric excess
• Include comparative toxicology data vs. racemic bupivacaine
• Declare specific rotation value for optical purity verification